Stephen Hitchcock
Direttore/Membro del Consiglio presso Structural Genomics Consortium
Profilo
Stephen Hitchcock is currently a Director at both the Structural Genomics Consortium and Cerevance, Inc. Previously, he worked as an Executive Director-Medicinal Chemistry at Amgen, Inc., a Principal at Eli Lilly & Co., and a Senior Vice President-Drug Discovery at Envoy Therapeutics, Inc. He holds a doctorate degree from The University of Nottingham.
Posizioni attive di Stephen Hitchcock
| Società | Posizione | Inizio |
|---|---|---|
Structural Genomics Consortium
 Structural Genomics Consortium Miscellaneous Commercial ServicesCommercial Services The Structural Genomics Consortium is a non-profit organization that accelerates research by sharing all of its research output with the scientific community without any restrictions. The private company is based in Headington, UK. The British company has created an open collaborative network of scientists in hundreds of universities worldwide and nine pharmaceutical companies. The company was founded by Pär Nordlund. | Direttore/Membro del Consiglio | - |
Cerevance, Inc.
 Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Stephen Hitchcock
| Società | Posizione | Fine |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Envoy Therapeutics, Inc.
 Envoy Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Envoy Therapeutics, Inc. manufactures and develops therapeutic drugs for neurological and psychiatric diseases. It was founded in 2009 and is headquartered in Jupiter, FL. | Corporate Officer/Principal | - |
Formazione di Stephen Hitchcock
| The University of Nottingham | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Aziende private | 3 |
|---|---|
Envoy Therapeutics, Inc.
Envoy Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Envoy Therapeutics, Inc. manufactures and develops therapeutic drugs for neurological and psychiatric diseases. It was founded in 2009 and is headquartered in Jupiter, FL. | Health Technology |
Structural Genomics Consortium
Structural Genomics Consortium Miscellaneous Commercial ServicesCommercial Services The Structural Genomics Consortium is a non-profit organization that accelerates research by sharing all of its research output with the scientific community without any restrictions. The private company is based in Headington, UK. The British company has created an open collaborative network of scientists in hundreds of universities worldwide and nine pharmaceutical companies. The company was founded by Pär Nordlund. | Commercial Services |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Stephen Hitchcock
